Vimarsana
Biggest News Aggregation in the World

Page 11 - Agena Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Agena Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Agena Bioscience Today - Breaking & Trending Today

Ethos Laboratories and Agena BioSciences Announce Strategic Partnership to Streamline SARS-CoV-2 Variant Detection - Vimarsana News

Ethos Laboratories and Agena BioSciences Announce Strategic Partnership to Streamline SARS-CoV-2 Variant Detection

Share this article Share this article NEWPORT, Ky., April 13, 2021 /PRNewswire/ -- Ethos Laboratories®, a national leader in laboratory testing, has announced a strategic partnership with Agena® Biosciences which will leverage Agena's innovative MassARRAY MALDI-TOF platform for high throughput SARS-CoV-2 variant detection. Next generation sequencing (NGS) technologies have traditionally been employed for variant detection but due to high cost, low sample throughput and the need for extensive bioinformatics, these platforms are not well suited to high throughput testing. Given these shortco...

Agena Bioscience Signs Exclusive Distribution Agreement with AGBL Group of Companies - Vimarsana News

Agena Bioscience Signs Exclusive Distribution Agreement with AGBL Group of Companies

Agena Bioscience Signs Exclusive Distribution Agreement with AGBL Group of Companies News provided by Share this article Share this article SAN DIEGO, March 10, 2021 /PRNewswire/ -- Agena Bioscience®, the global manufacturer of the MassARRAY® System for targeted genetic analysis, today announced an exclusive distribution agreement with Alliance Global, the AGBL Group of companies, to bring the MassARRAY technology to many emerging markets across the Middle East, Africa, and Central Asia. "With their extensive biomedical distribution network, AGBL is an ideal partner to bring our high-thro...

Alliance Global Signs Exclusive Distribution Agreement with Agena Bioscience - Vimarsana News

Alliance Global Signs Exclusive Distribution Agreement with Agena Bioscience

Alliance Global Signs Exclusive Distribution Agreement with Agena Bioscience DUBAI, UAE, March 10, 2021 /PRNewswire/ -- Agena Bioscience, the global manufacturer of the MassARRAY System for targeted genetic analysis has signed an exclusive distribution agreement with Alliance Global (AGBL Group) to bring the MassARRAY technology to many emerging markets across the Middle East, Africa, and Central Asia. "With their extensive biomedical distribution network, AGBL is an ideal partner to bring our high-throughput, low-cost, targeted genotyping solution to these emerging healthcare markets," said ...

Agena Bioscience Launches New Panel for Detection and Discrimination of SARS-CoV-2 Variants of Concern - Vimarsana News

Agena Bioscience Launches New Panel for Detection and Discrimination of SARS-CoV-2 Variants of Concern

Share this article Share this article SAN DIEGO, March 1, 2021 /PRNewswire/ -- Agena Bioscience®, a global provider of low-cost, high-throughput molecular testing solutions, today announced the launch of the MassARRAY® SARS-CoV-2 Variant Panel (RUO) for the detection of key SARS-CoV-2 virus strains, including the UK (B.1.1.7), South Africa (B.1.351), Brazil (P.1) and Denmark (Cluster 5) variants. The MassARRAY® technology is a benchtop system that provides timely and accurate analysis of up to 1000s of samples in a single day. For SARS-CoV-2, influenza A, and influenza B targets, the plat...

Surging Nephrology Disorders Fuel Adoption of Serological Transplant Diagnostics: Fact.MR - Vimarsana News

Surging Nephrology Disorders Fuel Adoption of Serological Transplant Diagnostics: Fact.MR

Share this article Share this article NEW YORK, Feb. 24, 2021 /PRNewswire/ -- Award winning market research company Fact.MR has recently published a report on the global serological transplant diagnostics market. According to the study, the market is expected to receive significant impetus in 2021 as organ transplantation procedures acquire momentum after a brief lull experienced due to the COVID-19 pandemic. Long-term prospects appear modest, with Fact.MR projecting a CAGR of 2.5% through 2031. Growth is majorly underpinned by increasing incidences of nephrology disorders. According to the G...